24 Top Young Southeastern Life Science Firms to Strut Their Stuff at Investor Forum

	Share this: September 28, 2011
	24 Top Young Southeastern Life Science Firms to Strut Their Stuff at Investor Forum Creative new drug therapies, advanced medical devices, diagnostics and nanotechnologies from throughout the Southeast will be in the spotlight November 2 and 3 during the 2011 Southeast BIO Investor Forum at the Washington Duke Inn in Durham, N.C. Entrepreneurs representing 24 of the most promising bioscience companies in the seven-state region will solicit advice and venture capital during the annual life science confab sponsored by Southeast BIO (SEBIO), the regional nonprofit organization dedicated to fostering the growth of the Southeast's life sciences industry. Eight MAIN/Stage presenters and 16 EARLY/Stage companies were picked by a selection committee of regional and national venture capitalists. Ten were from North Carolina, four each from South Carolina and Florida, two each from Tennessee and Virginia, and one each from Georgia and Alabama. The MAIN/Stage presenting companies have generally completed at least one round of institutional financing and will each have the opportunity to make a 10-minute pitch to the full conference audience on the afternoon of November 2. Those companies chosen for the EARLY/Stage event are seeking their first rounds of venture capital and/or angel investment. During the Investor Forum, the companies will participate in a private advisory session led by active early-stage investors, entrepreneurs and experienced life science managers and service providers. Four EARLY/Stage companies will be selected to present to the full conference audience, and an overall "winner" will be announced at the closing lunch. "Scientific discovery and innovation haven't stopped, despite the current economic slowdown," said Douglas Reed, Chair of the SEBIO Selection Committee and General Partner at Hatteras Venture Partners. "We are very pleased to be able to showcase a large number of highly promising companies at SEBIO this year. Many of these emerging companies are well on their way to developing important new products or services that will improve treatment options for patients and physicians." Since 1999, companies that have participated in the SEBIO Investor Forum have raised more than $2.5 billion in public and private offerings, making it the region's most successful venue for linking industry investors with the Southeast's top life science companies. Companies chosen for presentations at this year’s event include: MAIN/Stage ABT Molecular Imaging, Inc. (Knoxville, TN) Altor BioScience Corp. (Miramar, FL) CivaTech Oncology (Research Triangle Park, NC) Elenza, Inc. (Roanoke, VA) Envoy Therapeutics, Inc. (Jupiter, FL) Liquidia Technologies (Research Triangle Park, NC) Metabolon, Inc. (Durham, NC) Viamet Pharmaceuticals (Morrisville, NC) EARLY/Stage ActivBiotics Pharma (Tucker, GA) Arborvax, Inc. (Raleigh, NC) Claro Scientific, LLC (St. Petersburg, FL) Clinical Sensors, Inc. (Chapel Hill, NC) GLG Pharma, LLC (Jupiter, FL) G-Zero Therapeutics (Chapel Hill, NC) iTi Health (Crozet, VA) KOR Therapies, LLC (Hoover, AL) Lumena Pharmaceuticals (Durham, NC) Madeira Therapeutics, LLC (Mount Pleasant, SC) NellOne Therapeutics, Inc. (Oak Ridge, TN) Pique Therapeutics (Durham, NC) Smart Perfusion, LLC (Denver, NC) Sphingogene, Inc. (Mt. Pleasant, SC) Vitasol, Inc. (Columbia, SC) ZYMAB (Charleston, SC) To learn more about the 2011 SEBIO Investor Forum and to register, please visit: SEBIO 2011.